🔎 Trials Near Me

Acasă › Leucemie limfoblastică acută › Massachusetts

Studii clinice pentru Leucemie limfoblastică acută în Massachusetts

15 studii pentru Leucemie limfoblastică acută caută participanți în Massachusetts.

Orașe în Massachusetts

Text oficial al studiului (în engleză)

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

  • Dana-Farber/Boston Children s Hospital, Boston
În curs de recrutare
Vârste de la 1 la 25 · Toate sexele · Actualizat 2 oct. 2026 · NCT05621291

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 1/2
Vârste de la 16 la 75 · Toate sexele · Actualizat 10 sept. 2026 · NCT03104491

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 1/2
Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241

ALL Backbone in AYAs

  • Dana Farber Cancer Institute, Boston
În curs de recrutareFaza 2
Vârste de la 18 la 51 · Toate sexele · Actualizat 17 aug. 2026 · NCT07227584

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

  • Children's Hospital Corporation d/b/a Boston Children's Hospital, Boston
În curs de recrutareStudiu observațional
1 Day – 17 Years · Toate sexele · Actualizat 14 aug. 2026 · NCT06274788

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • Brigham and Women's Hospital, Boston
În curs de recrutareFaza 1Voluntari sănătoși bineveniți
Vârste de la 18 la 75 · Toate sexele · Actualizat 28 iul. 2026 · NCT07020533

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Tufts Medical Center, Boston
  • Beth Israel Deaconess, Boston
  • Dana Farber Cancer Institute, Boston
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 18 mai 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • Dana Farber Cancer Institute, Boston
În curs de recrutareFaza 1
Vârste de 13 ani și peste · Toate sexele · Actualizat 5 mai 2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Massachusetts General Hospital, Boston
În curs de recrutareFaza 1/2
Vârste de 12 ani și peste · Toate sexele · Actualizat 24 mar. 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 2
Vârste de la 18 la 66 · Toate sexele · Actualizat 17 mar. 2026 · NCT06859424

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 1
Vârste de la 1 la 40 · Toate sexele · Actualizat 12 mar. 2026 · NCT05292664

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • DFCI/BWH Brigham and Women's Hospital, Boston
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
Vârste de la 18 la 75 · Toate sexele · Actualizat 10 mar. 2026 · NCT06059391

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 15 apr. 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Dana-Farber Cancer Institute, Boston
În curs de recrutareFaza 1
Vârste de la 1 la 21 · Toate sexele · Actualizat 6 dec. 2024 · NCT05476770

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.